Anip Acquisition CO
Doing business as Ani Pharmaceuticals, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersBaudette, MN
US patents7
SAM.gov UEIT2M8DGLHA8V3
CAGE code52BX0
Incorporated inDE
- contract manufacturing
- generics
- FDA approved
- NASDAQ
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
7 US patents granted 2024–2025, 7 of them in the five years to SEP 2025.
Pharmaceuticals 7
- Stable oral suspensions of baclofenUS 12,350,245 · granted JUL 8, 2025
- Kits for preparing and delivering purified corticotropinUS 12,324,787 · granted JUN 10, 2025
- Methods for storing and warming purified corticotropin compositionsUS 12,233,105 · granted FEB 25, 2025
- Kits for preparing and delivering purified corticotropinUS 12,133,831 · granted NOV 5, 2024
- Methods for storing and warming purified corticotropin compositionsUS 12,102,662 · granted OCT 1, 2024
Newest 5 shown · Granted to ANI Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Anip Acquisition CO | Baudette | MN | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.